Back to the future: DCB use instead of DES for the treatment of complex, native coronary artery disease
| Autor: | Bernardo Cortese, Erick Sanchez-Jimenez |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Drug-coated balloons Surgical approach business.industry medicine.medical_treatment Percutaneous coronary intervention Disease Articles medicine.disease Revascularization Coronary artery disease Restenosis Drug-eluting stent Complex coronary lesions medicine In patient AcademicSubjects/MED00200 Cardiology and Cardiovascular Medicine Intensive care medicine business |
| Zdroj: | European Heart Journal Supplements : Journal of the European Society of Cardiology |
| ISSN: | 1554-2815 1520-765X |
| Popis: | The increasing complexity of coronary artery lesions in patients with significant co-morbidities and the need for revascularization, but with the ineligibility for surgical approach, has turned the percutaneous coronary intervention a challenging task, especially in a setting in which short- and long-term complications after drug-eluting stent implantation are high. Drug-coated balloons (DCBs) have become an important tool to replace stent placement in specific situations such as small coronary artery disease and in-stent restenosis. Although preliminary data of DCB use in complex lesions is promising, the available data are still limited. Therefore, in this article, we review the most recent and relevant literature about the use of DCB in native vessel disease and in complex anatomies/patients, and pretend to justify the necessity to develop well design trials about the use of this therapy in such settings, also thinking at DCBs as a complementary tool to drug-eluting stents. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|